検索結果

お知らせ | 千寿製薬株式会社

BAC-free formulation of Aibeta® combination eye drops（PDF） March 7, 2025 Announcement of Licensing Agreement with Brill International（PDF） February 20, 2025 Launch and Distribution of “MIEr for Beeli...

quarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter: Senju) is developing a TRPV1 antagonist (development code: SJP-0132) discovered by Mochida Pharmaceutical Co., Ltd. (Head office: To...

d by ocular surface disorder” *. Recently, the number of DED patients has been increasing due to an aging population, the long-term use of contact lenses, and the widespread use of Visual Display Term...

nding under the program Cyclic Innovation for Clinical Empowerment (CiCLE) established by the Japan Agency for Medical Research and Development (AMED). (1) Hayreh SS, and Zimmerman MB. Central retinal...

nding under the program Cyclic Innovation for Clinical Empowerment (CiCLE) established by the Japan Agency for Medical Research and Development (AMED). (1) Hayreh SS, and Zimmerman MB. Central retinal...